Cancer Immunotherapy, Volume 165 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to different approaches to cancer immunotherapy, with this release focusing on TNFR2 in cancer immunology and immunotherapy, From the Hellstrom paradox towards cancer cure, CAR T-cell treatment of T-cell malignancy , Immunotherapy of pancreatic cancer, Cancer stem cell immunology/immunotherapy,
Cytokine release syndrome, Tumor cell-based mechanisms of resistance to immune attack, and Mushroom compounds in cancer immunotherapy.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: From the Hellstrom paradox toward cancer cure - p. xvi 8. Chapter Two: Bioinformatic methods for cancer neoantigen prediction - p. 24 9. Chapter Three: Tumor mechanisms of resistance to immune attack - p. 60 10. Chapter Four: TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy - p. 100 11. Chapter Five: Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source - p. 117 12. Chapter Six: Immunotherapy of pancreatic cancer - p. 188 13. Chapter Seven: Synergistic combination of oncolytic virotherapy with CAR T-cell therapy - p. 216 14. Chapter Eight: Application of CAR T cells for the treatment of solid tumors - p. 292 15. Index - p. 329
Cancer Immunotherapy, Volume 165 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to different approaches to cancer immunotherapy, with this release focusing on TNFR2 in cancer immunology and immunotherapy, From the Hellstrom paradox towards cancer cure, CAR T-cell treatment of T-cell malignancy , Immunotherapy of pancreatic cancer, Cancer stem cell immunology/immunotherapy,
Cytokine release syndrome, Tumor cell-based mechanisms of resistance to immune attack, and Mushroom compounds in cancer immunotherapy.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter One: From the Hellstrom paradox toward cancer cure - p. xvi 8. Chapter Two: Bioinformatic methods for cancer neoantigen prediction - p. 24 9. Chapter Three: Tumor mechanisms of resistance to immune attack - p. 60 10. Chapter Four: TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy - p. 100 11. Chapter Five: Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source - p. 117 12. Chapter Six: Immunotherapy of pancreatic cancer - p. 188 13. Chapter Seven: Synergistic combination of oncolytic virotherapy with CAR T-cell therapy - p. 216 14. Chapter Eight: Application of CAR T cells for the treatment of solid tumors - p. 292 15. Index - p. 329
